“…This finding was comparatively lower than a study conducted in different areas of Ethiopia like Amhara region Northwest Ethiopia 27.7%, 27 to a study conducted among 12,980 Ethiopian study participants 25.59%, 38 to a study that was done in Bahir Dar Flege Hiwot specialized hospital 10.1%, 39 a facility-based retrospective study conducted at Hawassa University referral hospital of Ethiopia reported that 18.2%, 40 another cross-sectional study (n=1153) that was done at private health institutions in Ethiopia 20%, 41 and a retrospective study at Butajira Zonal hospital, Ethiopia that founds 20.3%. 9 Not only from local studies but also abroad studies have shown that the higher magnitude of PTB among HIVpositive individuals including from South India 60.58%, 42 Nigeria 42.3%, 43 Tanzania (11.0%) participants developed TB while receiving ART, 37 and the prevalence rate of TB while receiving ART from South Africa reported 10%. 44 The discrepancy in the magnitude of TB among HIVpositive participants may be explained by the difference in the health-care system among ART centres, variation in study design, 45 the diagnostic methods 46 employed (smear microscopy, culture, GeneXpert), ART regimens and its adherence 47 and adverse drug-related problems that trigger MTB-MDR.…”